MAI Capital Management cut its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 169,375 shares of the healthcare conglomerate's stock after selling 4,672 shares during the quarter. UnitedHealth Group accounts for about 0.9% of MAI Capital Management's holdings, making the stock its 22nd biggest holding. MAI Capital Management's holdings in UnitedHealth Group were worth $99,030,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of UNH. Tealwood Asset Management Inc. acquired a new stake in UnitedHealth Group during the third quarter worth approximately $2,905,000. Asset Planning Services Inc. LA ADV boosted its position in shares of UnitedHealth Group by 1.2% during the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate's stock valued at $7,288,000 after buying an additional 150 shares during the last quarter. Sequoia Financial Advisors LLC lifted its holdings in UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate's stock worth $14,603,000 after acquiring an additional 3,006 shares during the period. Americana Partners LLC raised its stake in shares of UnitedHealth Group by 10.8% in the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate's stock valued at $11,914,000 after buying an additional 1,984 shares during the period. Finally, Hennion & Walsh Asset Management Inc. raised its stake in shares of UnitedHealth Group by 14.8% in the second quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate's stock valued at $5,072,000 after buying an additional 1,283 shares during the period. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Stock Down 0.4 %
UNH traded down $2.58 during trading on Monday, hitting $589.65. 2,577,075 shares of the company's stock traded hands, compared to its average volume of 3,883,119. The company's 50 day simple moving average is $582.75 and its two-hundred day simple moving average is $550.66. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market capitalization of $542.64 billion, a price-to-earnings ratio of 38.41, a PEG ratio of 1.74 and a beta of 0.58.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion for the quarter, compared to analysts' expectations of $99.14 billion. During the same period in the prior year, the firm earned $6.56 EPS. The company's revenue was up 9.2% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group's payout ratio is 54.72%.
Analysts Set New Price Targets
Several equities analysts recently commented on the company. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th. Stephens lowered their price target on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. KeyCorp initiated coverage on UnitedHealth Group in a research report on Friday, October 11th. They set an "overweight" rating and a $675.00 price target for the company. Finally, TD Cowen upped their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a "buy" rating in a research report on Friday, October 18th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $615.53.
Read Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.